Fostering the development of AI-enhanced technologies to support healthy aging at home for older adults and individuals with Alzheimer’s disease.
Featured Pilots
Using AI to Repurpose Small Molecules to Target Amyloid-tau Interactions in AD
Investigators:
Jeremy Linsley, Operant BioPharma
Accelerating Balance Recovery Using Adaptive EVS Therapy
Investigators:
John Ralston, Neursantys Inc.
VP Nguyen, UMass Amherst
Voiceitt: AI-Enabled Speech Recognition for Older Adults with Severe Dysarthria
Investigators:
Katie Seaver, The Babel Group
Rachel Levy, The Babel Group
News & Events
-
Register – Listening to the Heart: In-Ear Infrasonic Technology for Blood Pressure and BeyondOctober 31, 2025/0 Comments -
-
-
